David R. Gastfriend, MD, DFASAM
40 ára afmælisráðstefna SÁÁ: What We Know & Don’t Know About Technology for Assessment, Pharmacotherapy and Contingency Management? David R. Gastfriend, MD, DFASAM, Chief Architect, CONTINUUM – The ASAM Criteria Decision Engine™; Chief Medical Officer & Co-Founder, DynamiCare Health, Inc.; Scientific Advisor, Treatment Research Institute Abstract Technology can enhance healthcare access and quality. Academic-entrepreneurial partnerships have …Read more »
Kaarlo Simojoki MD, PhD
40 ára afmælisráðstefna SÁÁ: New patterns in addiction in Finland and challenges for the addiction treatment system Kaarlo Simojoki MD, PhD, Chief Medical Officer of the A-Clinic Foundation Languages: Finnish German English Swedish Training: 1999 M.D. at University of Helsinki 2006 Specialist in Addiction Medicine 2013 Ph.D at University of Helsinki Current position: Medical Director …Read more »
Þórarinn Tyrfingsson, læknir
Erindi Þórarins Tyrfingssonar MD, past Medical Director at SÁÁ SÁÁ´s 40 years of addiction treatment
Patrick G. O’Connor, M.D., M.P.H., F.A.C.P.
40 ára afmælisráðstefna SÁÁ Patrick G. O’Connor, MD, MPH, Professor of General Medicine, Chief, General Internal Medicine, Yale School of Medicine Dr. Patrick O’Connor is a Dan Adams and Amanda Adams Professor of General Medicine and Chief of General Internal Medicine at Yale University School of Medicine and Yale-New Haven Hospital in New Haven, Connecticut. …Read more »
Nora D. Volkow, Director of the NIDA
40 ára afmælisráðstefna SÁÁ: Addiction Is a Chronic Brain Disease – What We Know Today Nora D. Volkow, MD, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) Abstract Addiction is a disorder that involves complex interactions between genes, development and the social environment. Studies employing neuroimaging technology paired …Read more »
Óttarr Proppé, Minister of Health
Opening, honorary remarks – Óttarr Proppé, Minister of Health
